
NKI | Netherlands Cancer Institute
Apr 15, 2025 · The NKI is an internationally renowned cancer research institute in Amsterdam with a long history of important contributions to the basic and clinical sciences that have deeply influenced our understanding of cancer and the control and treatment of the disease.
Organization | Netherlands Cancer Institute - NKI
The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), founded in 1913 and based in Amsterdam, is an independent comprehensive cancer center, comprising a hospital and research laboratories under one roof in a single independent organization.
Research | Netherlands Cancer Institute - NKI
At the Netherlands Cancer Institute, over 750 scientists and scientific support staff members conduct cutting-edge research in order to improve the prospects of cancer patients – from fundamental research to clinical applications, and everything in between.
Services | Netherlands Cancer Institute - NKI
The document prescribes precision review processes for studies that involve human material and derived data. The NKI-AVL, adheres to this Code of Conduct (Human Tissue and Medical Research: Code of conduct for responsible use).
Research groups | Netherlands Cancer Institute - NKI
Find research groups at the NKI | Learn more about former faculty members which have made important contributions to our institute.
About us | Netherlands Cancer Institute - NKI
The NKI is among the top 10 comprehensive cancer centers, combining world-class fundamental, translational and clinical research with dedicated patient care.
How to apply | Netherlands Cancer Institute - NKI
If you are already insured with Zorg & Zekerheid, you can also profit from our collective agreements by linking your current policy to the Antoni van Leeuwenhoek collectivity. The Collectivity code is 35751 or enter the name Antoni van Leeuwenhoek or AVL. Various Supplemental Insurance Policies
Find a researcher | Netherlands Cancer Institute - NKI
Find a researcher at the NKI | Learn more about their fields of expertise, work experience, research group participation and contact details.
Lonneke van de Poll - NKI
Breast cancer patients can, as a result of their treatment, suffer from complaints that affect the quality of their life. A study by Kelly de Ligt (Antoni van Leeuwenhoek) and researchers from IKNL and Nivel maps the extent to which women experience multiple complaints at the same time and what the influence is on their quality of life.
Contact us | Netherlands Cancer Institute - NKI
Phone: +31 20 512 9111 | Email: [email protected] | Visiting address: Plesmanlaan 121, 1066 CX Amsterdam | Find additional contact details